Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

enVVeno Medical (NVNO) Non-cash Items (2017 - 2026)

enVVeno Medical has reported Non-cash Items over the past 4 years, most recently at $1.8 million for Q4 2020.

  • For Q4 2020, Non-cash Items rose 163.7% year-over-year to $1.8 million; the TTM value through Dec 2020 reached $2.9 million, up 67.75%, while the annual FY2022 figure was $9.0 million, 93.38% up from the prior year.
  • Non-cash Items for Q4 2020 was $1.8 million at enVVeno Medical, up from $1.1 million in the prior quarter.
  • Over five years, Non-cash Items peaked at $3.1 million in Q1 2018 and troughed at $7630.0 in Q1 2020.
  • A 4-year average of $1.0 million and a median of $856540.0 in 2017 define the central range for Non-cash Items.
  • Biggest five-year swings in Non-cash Items: crashed 97.43% in 2019 and later skyrocketed 163.7% in 2020.
  • Year by year, Non-cash Items stood at $1.9 million in 2017, then tumbled by 81.81% to $336944.0 in 2018, then soared by 98.11% to $667532.0 in 2019, then skyrocketed by 163.7% to $1.8 million in 2020.
  • Business Quant data shows Non-cash Items for NVNO at $1.8 million in Q4 2020, $1.1 million in Q3 2020, and $148650.0 in Q2 2020.